Hikma Pharmaceutical reported 751M in Loan Capital for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
AstraZeneca AZN:LN 28939M 4338M
Bayer BAYN:GR € 36974M 310M
Fresenius FRE:GR € 22142M 127M
Fresenius Medical Care FMS:US $ 10570M 100.97M
Galapagos GLPG:NA 19.13M 2.3M
Genmab GEN:DC 374M 10M
GlaxoSmithKline GSK:LN 20736M 294M
GRIFOLS GRF:SM € 6978M 247.04M
H. Lundbeck A/S LUN:DC 5.5B 212M
Hikma Pharmaceutical HIK:LN 751M 13M
Lonza Group LONN:SW 2.79B 5M
Merck MRK:GR € 8195M 526M
Orion ORNBV:FH 104.7M 200K
Recordati REC:IM 824.7M 70.95M